Schedule

Print
Sunday · April 28, 2019
6:30am to 7:45am Registration and Breakfast
7:45am to 8:00am Seating
8:00am to 8:15am Welcome, Introductions, Course Objectives

Samuel Z. Goldhaber, MD, Peter Libby, MD, and Patrick T. O'Gara, MD

Atherosclerosis, Inflammation, Thrombosis, and Risk Factors

Co-Chairs: Samuel Z. Goldhaber, MD and Patrick T. O'Gara, MD
8:15am to 8:45am Inflammation: At the Nexus of Atherosclerosis, Aging, and Cancer

Peter Libby, MD
8:45am to 8:55am Discussion, Q&A
8:55am to 9:25am CANTOS: Effect of Interleukin-1β Inhibition with Canakinumab on Atherosclerosis and Lung Cancer

Paul M Ridker, MD, MPH
9:25am to 9:35am Discussion, Q&A
9:35am to 10:05am Reducing Triglyceride Levels to Reduce Adverse Cardiovascular Outcomes

Aruna D. Pradhan, MD, MPH
10:05am to 10:15am Discussion, Q&A
10:15am to 10:35am Coffee break

Refreshments provided
10:35am to 11:05am Statins, Ezetimibe, and PCSK9 Inhibitors to Lower LDL Cholesterol: How Low Can You Go?

Jorge Plutzky, MD
11:05am to 11:15am Discussion, Q&A

Thomas W. Smith, MD Memorial Lecture

Session Chair: Peter Libby, MD
11:15am to 12:00pm Heart Failure with Preserved Ejection Fraction

Nancy K. Sweitzer, MD, PhD
12:00pm to 12:10pm Discussion, Q&A
12:10pm to 1:10pm Break for lunch*

Advanced Heart Failure

Session Chairs: Akshay S Desai, MD, MPH and Anju Nohria, MD
1:10pm to 1:40pm Ventricular Assist Devices and the Artificial Heart

Mandeep Mehra, MD
1:40pm to 1:50pm Discussion, Q&A
1:50pm to 2:20pm Cardiac Transplantation: Current and Future Perspectives

Michael M. Givertz, MD
2:20pm to 2:30pm Discussion, Q&A
2:30pm to 3:00pm Heart Failure with Reduced Ejection Fraction

Akshay S. Desai, MD, MPH
3:00pm to 3:10pm Discussion, Q&A
3:10pm to 3:40pm Health-Related Quality of Life Outcomes in Heart Failure

Eldrin F. Lewis, MD, MPH
3:40pm to 3:50pm Discussion, Q&A
3:50pm to 4:10pm Snack break

Refreshments provided
4:10pm to 4:40pm Cardiac Amyloidosis: New Treatments, New Hope

Rodney H. Falk, MD
4:40pm to 4:50pm Discussion, Q&A
4:50pm to 5:20pm The Burgeoning Field of Cardio-Oncology

Anju Nohria, MD
5:20pm to 5:30pm Discussion, Q&A
5:30pm to 6:00pm Heart Failure in Adult Congenital Heart Disease: An Echocardiographic Montage

Keri Shafer, MD
6:00pm to 6:10pm Discussion, Q&A
Monday · April 29, 2019
6:30am to 7:45am Breakfast
7:45am to 8:00am Seating

Atrial Fibrillation

Session Chairs: Usha Tedrow, MD and Paul Zei, MD, PhD
8:00am to 8:30am Epidemiology of Atrial Fibrillation: New Emphasis on Modification of Cardiovascular Risk Factors and New Concept of Atrial Fibrillation as a Systemic Cardiovascular Illness

Usha Tedrow, MD
8:30am to 8:40am Discussion, Q&A
8:40am to 9:10am Atrial Fibrillation: Pharmacological Therapy and New Approaches to Ablation in the EP Lab

Paul Zei, MD, PhD
9:10am to 9:20am Discussion, Q&A
9:20am to 9:50am Management of Atrial Fibrillation by the General Cardiologist: Lessons from Randomized and Observational Clinical Trials

David T. Martin, MD
9:50am to 10:00am Discussion, Q&A
10:00am to 10:20am Coffee break

Refreshments provided
10:20am to 10:50am Is There a Role for Electronic Decision Support in the Management of Atrial Fibrillation and Other Cardiovascular Illnesses?

Samuel Z. Goldhaber, MD
10:50am to 11:00am Discussion, Q&A
11:00am to 11:30am Atrial Fibrillation in Hypertrophic Cardiomyopathy: Pathogenesis and Management

Neal K. Lakdawala, MD, MSc
11:30am to 11:40am Discussion, Q&A

Master Mentor Featured Lecture
11:40am to 12:25pm Atrial Fibrillation and Coronary Artery Disease: A Perilous Combination

Deepak L. Bhatt, MD, MPH
12:25pm to 12:35pm Discussion, Q&A
12:35pm to 1:35pm Break for lunch*

Valvular Heart Disease: Diagnostic, Cath Lab, and Surgical Approaches
1:35pm to 2:05pm Tricuspid Valve Disease

Dale S. Adler, MD
2:05pm to 2:15pm Discussion, Q&A
2:15pm to 2:45pm Mitral Valve Disease

Patrick T. O'Gara, MD
2:45pm to 2:55pm Discussion, Q&A
2:55pm to 3:25pm Aortic Valve Disease

Yee-Ping Sun, MD
3:25pm to 3:35pm Discussion, Q&A
3:35pm to 3:55pm Snack break

Refreshments provided
3:55pm to 4:25pm Transcatheter Aortic Valve, Mitral Valve, and Tricuspid Valve Therapies

Pinak B. Shah, MD
4:25pm to 4:35pm Discussion, Q&A

Pulmonary Hypertension
4:35pm to 5:05pm Idiopathic Pulmonary Hypertension: Definition, Diagnosis, and Epidemiology

Bradley A. Maron, MD
5:05pm to 5:15pm Discussion, Q&A
5:15pm to 5:45pm Idiopathic Pulmonary Hypertension: Combination Pharmacological Therapy—Rationale and Results

Aaron B. Waxman, MD, PhD
5:45pm to 5:55pm Discussion, Q&A
5:55pm to 6:25pm Chronic Thromboembolic Pulmonary Hypertension

William Auger, MD
6:25pm to 6:35pm Discussion, Q&A
Tuesday · April 30, 2019
6:30am to 7:45am Breakfast
7:45am to 8:00am Seating

Coronary Artery Disease: Challenges and Conceptual Changes

Session Chair: Michelle L. O'Donoghue, MD, MPH
8:00am to 8:30am Management of Acute Coronary Syndromes

Marc S. Sabatine, MD, MPH
8:30am to 8:40am Discussion, Q&A
8:40am to 9:10am New Approaches to STEMI in the Cardiac Cath Lab: Should Our Goal Be Complete Revascularization? What Are Our Options for Intravenous Antiplatelet Therapy?

Brian A. Bergmark, MD
9:10am to 9:20am Discussion, Q&A
9:20am to 9:50am Long-Term Antiplatelet Therapy for Coronary Artery Disease: Single, Dual, or Even Triple Therapy? How Intense? Optimal Duration? Should Aspirin Be the First Antiplatelet Agent That We Discontinue?

Michelle L. O'Donoghue, MD, MPH
9:50am to 10:00am Discussion, Q&A
10:00am to 10:20am Coffee break

Refreshments provided
10:20am to 10:50am Total Coronary Occlusion: The Last Fronier and Greatest Challenge for the Interventionalist in the Cath Lab

Kevin J. Croce, MD, PhD
10:50am to 11:00am Discussion, Q&A
11:00am to 11:30am The Aspirin Perplex: Whom to Treat and What Dose to Use?

Samia Mora, MD
11:30am to 11:40am Discussion, Q&A

Kenneth L. Baughman, MD Memorial Lecture

Session Chair: Patrick T. O'Gara, MD
11:40am to 12:25pm Sudden Cardiac Death: Identifying Patients at High Risk, Optimizing Preventive Measures, and Managing Patients Who Are Successfully Resuscitated

Gordon F. Tomaselli, MD
12:25pm to 12:35pm Discussion, Q&A
12:35pm to 1:35pm Break for lunch*

Anticoagulation

Session Chair: Samuel Z. Goldhaber, MD
1:35pm to 2:05pm DOACs: The Good, the Bad, and the Ugly

Samuel Z. Goldhaber, MD
2:05pm to 2:15pm Discussion, Q&A
2:15pm to 2:45pm Management of Major Bleeding Complications in Anticoagulation Patients

Jean M. Connors, MD
2:45pm to 2:55pm Discussion, Q&A
2:55pm to 3:10pm Transition to Breakout Sessions

Breakout Sessions I, II, III

Program participants will have the opportunity to attend all three breakout sessions.
3:10pm to 4:00pm Breakout Sessions I, II, III

Session I: Difficult Dilemmas That My Patients and I Have Confronted
Patrick T. O'Gara, MD
Session II: Thrombophilia, Bleeding, and Clotting Cases
Umberto Campia, MD, MS
Session III: Vascular Medicine in the Office and Interventional Lab: Cases I'll Never Forget
Brian Bergmark, MD
4:00pm to 4:10pm Transition
4:10pm to 5:00pm Breakout Sessions I, II, III

Session I: Difficult Dilemmas That My Patients and I Have Confronted
Patrick T. O'Gara, MD
Session II: Thrombophilia, Bleeding, and Clotting Cases
Umberto Campia, MD, MS
Session III: Vascular Medicine in the Office and Interventional Lab: Cases I'll Never Forget
Brian Bergmark, MD
5:00pm to 5:10pm Transition
5:10pm to 6:00pm Breakout Sessions I, II, III

Session I: Difficult Dilemmas That My Patients and I Have Confronted
Patrick T. O'Gara, MD
Session II: Thrombophilia, Bleeding, and Clotting Cases
Umberto Campia, MD, MS
Session III: Vascular Medicine in the Office and Interventional Lab: Cases I'll Never Forget
Brian Bergmark, MD
Wednesday · May 1, 2019
6:30am to 7:45am Breakfast
7:45am to 8:00am Seating

Vascular Medicine

Session Chair: Patrick T. O'Gara, MD
7:30am to 7:50am Lymphedema and Limb Swelling: Assessment and Cutting Management

Brett Carroll, MD
7:50am to 8:00am Discussion, Q&A
8:00am to 8:30am Cold and Blue Fingers and Toes: Work-Up and Management

Marie D. Gerhard-Herman, MD
8:30am to 8:40am Discussion, Q&A
8:40am to 9:10am Pulmonary Embolism Response Teams: Optics and Options—Rolling Out a Coordinated Communications Strategy

Samuel Z. Goldhaber, MD
9:10am to 9:20am Discussion, Q&A
9:20am to 9:50am Pulmonary Embolism and DVT: Epidemiology, Pathophysiology, Misconceptions, and Management Overview

Samuel Z. Goldhaber, MD
9:50am to 10:00am Discussion, Q&A
10:00am to 10:20am Coffee break

Refreshments provided
10:20am to 10:50am Peripheral Arterial Disease: Lessons from the COMPASS Trial and Implementation of Combination Anticoagulation and Antiplatelet Therapy

Umberto Campia, MD, MS
10:50am to 11:00am Discussion, Q&A
11:00am to 11:30am Quiz: Vascular Diagnostic Lab Cases

Piotr Sobieszczyk, MD
11:30am to 11:40am Discussion, Q&A

Featured Presentation: Joseph Loscalzo, MD, PhD

Session Chair: Samuel Z. Goldhaber, MD
11:40am to 12:25pm Case Discussion: From Bedside to Bench

Joseph Loscalzo, MD, PhD
12:25pm to 12:35pm Discussion, Q&A
12:35pm to 1:35pm Break for lunch*

Electrophysiology

Session Chairs: Bruce Koplan, MD and Usha Tedrow, MD
1:35pm to 2:05pm Ventricular Tachycardia "Storm" and Other EP Emergencies: A Case-Based Approach to Management, including Ventricular Tachycardia Ablation

Usha Tedrow, MD
2:05pm to 2:15pm Discussion, Q&A
2:15pm to 2:45pm Rapid-Fire Case-Based Arrhythmia Quiz

Bruce Koplan, MD
2:45pm to 2:55pm Discussion, Q&A

Multimodality Cardiovascular Imaging and Stress Testing

Session Chairs: Justina C. Wu, MD, PhD and Marcelo F. DiCarli, MD
2:55pm to 3:25pm How to Select, Use, and Integrate the Results of Cardiovascular Imaging Tests: CT, Magnetic Resonance, and Nuclear Imaging

Ron Blankstein, MD
3:25pm to 3:35pm Discussion, Q&A
3:35pm to 3:55pm Coffee break

Refreshments provided
3:55pm to 4:25pm Challenges and Advances in Transthoracic and Transesophageal Echocardiography

Justina C. Wu, MD, PhD
4:25pm to 4:35pm Discussion, Q&A
4:35pm to 5:05pm How to Choose the Best Stress Test: Exercise Treadmill, Exercise Bicycle, Exercise ECHO, Nuclear, or Magnetic Resonance

Marcelo F. DiCarli, MD
5:05pm to 5:15pm Discussion, Q&A
5:15pm to 5:45pm Cardiac Magnetic Resonance Imaging: Sarcoid, Amyloid, Pericardial Inflammation, Hemochromatosis, and Other Cardiac Infiltrative Diseases

Raymond Y. Kwong, MD, MPH
5:45pm to 5:55pm Discussion, Q&A
5:55pm to 6:25pm Cardiopulmonary Exercise Testing: Indications, Noninvasive, and Invasive

Bradley A. Maron, MD
6:25pm to 6:35pm Discussion, Q&A
Thursday · May 2, 2019
6:30am to 7:45am Breakfast
7:45am to 8:00am Seating

Critical Care Cardiology

Session Chair: Samuel Z. Goldhaber, MD
8:00am to 8:30am The Emerging Field of Critical Care Cardiology: Managing Multisystem Organ Failure in Patients with Underlying Catastrophic Cardiac Insult

Erin Bohula, MD, DPhil
8:30am to 8:40am Discussion, Q&A

Genetics: Relevance to Daily Clinical Practice

Session Chair: Carolyn Y. Ho, MD
8:40am to 9:10am Primer on Essential Genetics for the Practicing Clinician: A Case-Based Approach

Rajat M. Gupta, MD
9:10am to 9:20am Discussion, Q&A
9:20am to 9:50am Implications of a Genetics Workup in Hypertrophic Cardiomyopathy: How Genetic Profiling Can Inform the Decision to Implant or Withhold an Internal Cardiac Defibrillator

Carolyn Y. Ho, MD
9:50am to 10:00am Discussion, Q&A
10:00am to 10:20am Coffee break

Refreshments provided
10:20am to 10:50am Arrhythmogenic Cardiomyopathy: When and Why Refer to a Cardiovascular Geneticist?

Neal K. Lakdawala, MD, MSc
10:50am to 11:00am Discussion, Q&A
11:00am to 11:30am Randomized and Observational Trials of Heart Failure: Lessons I Have Learned as a Clinician

Scott D. Solomon, MD
11:30am to 11:40am Discussion, Q&A

Featured Presentation: Eugene Braunwald, MD

Session Chair: Samuel Z. Goldhaber, MD
11:40am to 12:25pm Heart Disease: Past, Present, and Future

Eugene Braunwald, MD
12:25pm to 12:35pm Discussion, Q&A
12:35pm to 1:35pm Break for lunch*

Diabetes and Cardiovascular Disease: Engaging the Clinical Cardiologist

Session Chairs: Benjamin M. Scirica, MD and Jorge Plutzky, MD
1:35pm to 2:05pm Exponential Advances in Our Understanding of Pharmacological Therapy to Reduce Heart Attack, Stroke, and Cardiovascular Death in Patients with Diabetes: Gleaning Information from a Series of Remarkable Randomized Control Trials

Marc A. Pfeffer, MD, PhD
2:05pm to 2:15pm Discussion, Q&A
2:15pm to 2:45pm A New Day Dawns in Management of CV Risk in Diabetes Mellitus: Attacking from All the Angles

Benjamin M. Scirica, MD
2:45pm to 2:55pm Discussion, Q&A
2:55pm to 3:25pm Playing Against a Stacked Deck: Managing Cardiovascular Risk in Chronic Kidney Disease

Ajay Singh, MD
3:25pm to 3:35pm Discussion, Q&A
3:35pm to 4:05pm Diabetes Mellitus for the Clinical Cardiologist: A Step-Wise Approach to Management—Do We Have to Start with Metformin? Should We Prescribe Routinely the Newest Agents That Reduce Cardiovascular Outcomes with Only Modest Reduction of Hemoglobin A1C?

Enrico Cagliero, MD
4:05pm to 4:15pm Discussion, Q&A

Cardiovascular Management of Complicated Pregnancy

Session Chair: Samuel Z. Goldhaber, MD
4:15pm to 4:45pm Cardiovascular Management of Complicated Pregnancy

Anne Marie Valente, MD
4:45pm to 4:55pm Discussion, Q&A
4:55pm to 5:00pm Concluding Remarks and Wrap-Up

Samuel Z. Goldhaber, MD
5:00pm Course Adjourns

*There are many convenient and varied lunch options within a short walking distance of the course.